Trademark applications and grants for Panacos Pharmaceuticals Inc. Panacos Pharmaceuticals Inc has 13 trademark applications. The latest application filed is for "MATRAVIA"
Patent Application | Date |
---|---|
Methods of Eliciting Broadly Neutralizing Antibodies Targeting HIV-1 GP41 20110142847 - 11/928612 Wild; Carl T. ;   et al. | 2011-06-16 |
Inhibition of HIV-1 Replication by Disruption of the Processing of the Viral Capsid-Spacer Peptide 1 Protein 20100221264 - 12/498157 Salzwedel; Karl ;   et al. | 2010-09-02 |
Alpha-substituted Arylmethyl Piperazine Pyrazolo [1,5-alpha]Pyrimidine Amide Derivatives 20090215778 - 12/149178 Nitz; Theodore J. ;   et al. | 2009-08-27 |
Inhibition of HIV-1 Replication by Disruption of the Processing of the Viral Capsid-Spacer Peptide 1 Protein 20080233559 - 11/962315 SALZWEDEL; Karl ;   et al. | 2008-09-25 |
Antiretroviral combination therapy 20080039428 - 11/822032 Allaway; Graham ;   et al. | 2008-02-14 |
SEC | 0001133151 | PANACOS PHARMACEUTICALS INC |
SEC | 0001040017 | PANACOS PHARMACEUTICALS, INC. of DELAWARE |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.